European Geriatric Medicine

, Volume 9, Issue 2, pp 183–189 | Cite as

Bone mineral density in older patients with chronic heart failure is related to NYHA classification: a retrospective study

  • Yefei Fang
  • Liping Wang
  • Wenmin Xing
  • Qing Wu
  • Qian Tong
  • Yanbo Yu
  • Xiaoling Lv
  • Bozhong Wang
  • Guofu Wang
Research Paper



Discrepant results on relationship between chronic heart failure (CHF) and bone mineral density (BMD) have been reported and little has investigated the association between bone mass loss and New York Heart Association (NYHA) classification in CHF patients. This study aimed to assess whether BMD was associated with NYHA classification in older CHF patients.


It was a retrospective study and included 1049 stable CHF patients aged over 60 years in Zhejiang Hospital. BMD and T-score at femoral neck (FN) and lumbar spines over L2–L4 regions were measured using Dual-Energy X-ray Absorptiometry. One-way ANOVA was used to compare continuous data of different NYHA functional class. Categorical variables were compared by Chi-square analysis. Pearson or Spearman correlation test was used to analyze the association between BMD and NYHA class, clinical parameters, lab data, etc. Significant variables in the correlation test (P < 0.05) were then tested by a multivariate linear regression test with stepwise subset selection to identify independent factors predicting BMD.


There were significant differences in FN BMD and T score across NYHA class I–IV, and that L2–L4 BMD and T score in patients in NYHA class IV were significantly lower when compared with CHF participants in NYHA classes I, II, and III. Moreover, Pearson correlation test and multivariate linear regression test demonstrated that there were statistically significant correlations between bone densitometric parameters and NYHA class.


There was a significant correlation between BMD and T-score at lumbar spines over L2–L4 and FN and NYHA class, implying that early screening and comprehensive intervention for osteoporosis (OP) might be helpful for patients with CHF.


Chronic heart failure Osteoporosis Osteopenia Bone mineral density New York heart association 



This work was supported by the Grants from the National Natural Science Foundation of China (31670701), and the Natural Science Foundation of Zhejiang Province (Y15H050018).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study formal consent is not required.

Supplementary material

41999_2018_27_MOESM1_ESM.docx (17 kb)
Supplementary material 1 (DOCX 18 kb)


  1. 1.
    Anderson G (2010) chronic care: making the case for ongoing care. Robert Wood Johnson Foundation, New JerseyGoogle Scholar
  2. 2.
    Chen W, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ et al (2017) China cardiovascular diseases report 2015: a summary. J Geriatr Cardiol. 14(1):1–10PubMedPubMedCentralGoogle Scholar
  3. 3.
    Xiao L, Dan X, Yi QP, Sheng ZF, Wu XY, Wu XP et al (2015) Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives. Clin Interv Aging 10:1017–1033Google Scholar
  4. 4.
    Melton LR, Chrischilles EA, Cooper C, Lane AW, Riggs BL (1992) Perspective: how many women have osteoporosis? J Bone Miner Res 7(9):1005–1010CrossRefPubMedGoogle Scholar
  5. 5.
    Chen YH, Wu YW, Yang WS, Wang SS, Lee CM, Chou NK et al (2012) Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. PLoS ONE 7(8):e44242CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Terrovitis J, Zotos P, Kaldara E, Diakos N, Tseliou E, Vakrou S et al (2012) Bone mass loss in chronic heart failure is associated with secondary hyperparathyroidism and has prognostic significance. Eur J Heart Fail 14(3):326–332CrossRefPubMedGoogle Scholar
  7. 7.
    Jankowska EA, Jakubaszko J, Cwynar A, Majda J, Ponikowska B, Kustrzycka-Kratochwil D et al (2009) Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants. Eur J Heart Fail 11(1):28–38CrossRefPubMedGoogle Scholar
  8. 8.
    Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRefPubMedGoogle Scholar
  9. 9.
    Van Diepen S, Majumdar SR, Bakal JA, McAlister FA, Ezekowitz JA (2008) Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation 118(19):1946–1952CrossRefPubMedGoogle Scholar
  10. 10.
    Marcovitz PA, Tran HH, Franklin BA, O’Neill WW, Yerkey M, Boura J et al (2005) Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96(8):1059–1063CrossRefPubMedGoogle Scholar
  11. 11.
    Von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106(3):273–278CrossRefPubMedGoogle Scholar
  12. 12.
    Fohtung RB, Brown DL, Koh WJ, Bartz TN, Carbone LD, Civitelli R et al (2017) Bone mineral density and risk of heart failure in older adults: the cardiovascular health study. J Am Heart Assoc. 6(3):e004344CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V et al (1997) Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 103(3):197–207CrossRefPubMedGoogle Scholar
  14. 14.
    Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z et al (2004) Loss of bone minerals and strength in rats with aldosteronism. Am J Physiol Heart Circ Physiol. 287(5):H2023–H2026CrossRefPubMedGoogle Scholar
  15. 15.
    Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ et al (2009) Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail. 2(4):303–310CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Lim LS, Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Ensrud KE et al (2008) Osteoporotic fractures in men (MrOS) Study Group. Loop diuretic use and increased rates of hip bone loss in older men: the osteoporotic fractures in men study. Arch Intern Med 168(7):735–740CrossRefPubMedGoogle Scholar
  17. 17.
    Hsu BG, Chen YC, Ho GJ, Shih MH, Chou KC, Lin TY et al (2016) Inverse association between serum osteoprotegerin and bone mineral density in renal transplant recipients. Transplant Proc 48(3):864–869CrossRefPubMedGoogle Scholar
  18. 18.
    Prahash A, Lynch T (2004) B-type natriuretic peptide: a diagnostic, prognostic, and therapeutic tool in heart failure. Am J Crit Care 13(1):46–53PubMedGoogle Scholar
  19. 19.
    Troughton RW, Frampton CM, Brunner-La Rocca HP, Pfisterer M, Eurlings LW, Erntell H et al (2014) Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. Eur Heart J 35(23):1559–1567CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Chen YH, Wu YW, Yang WS, Wang SS, Lee CM, Chou NK et al (2012) Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. PLoS ONE 7(8):e44242CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Lee MC, Lee CJ, Shih MH, Ho GJ, Chen YC, Hsu BG (2014) N-terminal pro-B-type natriuretic peptide is inversely related to bone mineral density in renal transplant recipients. Transplant Proc. 46(10):3443–3447CrossRefPubMedGoogle Scholar
  22. 22.
    Wang CH, Tsai JP, Lai YH, Lin YL, Kuo CH, Hsu BG (2016) Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients. Ci Ji Yi Xue Za Zhi. 28(2):68–72PubMedPubMedCentralGoogle Scholar
  23. 23.
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475CrossRefPubMedGoogle Scholar
  24. 24.
    Qaseem A, Forciea MA, McLean RM, Denberg TD (2017) Clinical guidelines committee of the American College of Physicians. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical Practice guideline update from the American College of Physicians. Ann Intern Med 166(11):818–839CrossRefPubMedGoogle Scholar

Copyright information

© European Geriatric Medicine Society 2018

Authors and Affiliations

  • Yefei Fang
    • 1
    • 2
  • Liping Wang
    • 3
  • Wenmin Xing
    • 4
  • Qing Wu
    • 4
  • Qian Tong
    • 4
  • Yanbo Yu
    • 1
  • Xiaoling Lv
    • 4
  • Bozhong Wang
    • 4
  • Guofu Wang
    • 1
    • 4
  1. 1.Wenzhou Medical UniversityWenzhouChina
  2. 2.Yuyao People’s HospitalThe Affiliated Yangming HospitalNingboChina
  3. 3.Department of Pulmonary DiseaseThe Affiliated Hospital of Hangzhou Normal UniversityHangzhouChina
  4. 4.Department of GeriatricsZhejiang HospitalHangzhouChina

Personalised recommendations